FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Teva Pharmaceuticals Isotretinoin Capsules Recall

Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured fo…

Teva Pharmaceuticals USA, Inc · Parsippany, NJ

Risk level
Class II
Reported by FDA
Apr 15, 2026
Recall ID
D-0446-2026
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Isotretinoin Capsules starting Jan 12, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0446-2026 on Apr 15, 2026. Reason: Superpotent and Subpotent. Status: Ongoing.

Why it was recalled

Superpotent and Subpotent

Product description

Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack).

Lot numbers, UPCs & expiration codes

Lots 100075305 Exp date 06/2027, 100075512, Exp date 07/2027 & 100076103, Exp date 07/2027 .

Where it was sold

FL, OH, PR & MS

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0446-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jan 12, 2026
FDA report date
Apr 15, 2026
Quantity
8376 packages
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA, Inc

Original FDA data

Every field from FDA enforcement report D-0446-2026, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Ongoing
Country
United States
Event ID
98275
Address
400 Interpace Pkwy Bldg A
Code information
Lots 100075305 Exp date 06/2027, 100075512, Exp date 07/2027 & 100076103, Exp date 07/2027 .
Postal code
07054-1120
Report date
Apr 15, 2026
Product type
Drugs
Recall number
D-0446-2026
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA, Inc
Product quantity
8376 packages
Reason for recall
Superpotent and Subpotent
Voluntary / mandated
Voluntary: Firm initiated
Product description
Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister pack).
Distribution pattern
FL, OH, PR & MS
Recall initiation date
Jan 12, 2026
Initial firm notification
Letter
Center classification date
Apr 8, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0446-2026, published Apr 15, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls